Table 3 Number (%) of preventive medicine organisations implementing NCD surveillance components
Implementation of surveillance components | PHI (n = 6) | Centre for Disease Control (CDC) (n = 53) | CHS (n = 148) |
|---|---|---|---|
Mortality surveillance | 4 (66.7%) | 53 (100%) | 146 (98.6%) |
Collecting data from commune level | 4 (66.7%) | 53 (100%) | 126 (85.1%) |
Conducting mortality surveysa | 0 | 1 (1.9%) | 20 (13.5%) |
Morbidity surveillance | 6 (100%) | 53 (100%) | 143 (96.6%) |
Hypertension/CVS | 6 (100%) | 53 (100%) | 143 (96.6%) |
Diabetes | 6 (100%) | 50 (94.3%) | 120 (81.1%) |
Chronic obstructive pulmonary disease (COPD)/ Asthma | 3 (50.0%) | 31 (58.5%) | 87 (58.8%) |
Risk factor surveillancea | 6 (100%) | 53 (100%) | - |
WHO risk factor survey | 6 (100%) | 53 (100%) | - |
Tobacco survey | 1 (16.7%) | 15 (28.3%) | - |
School health survey | 0 | 1 (1.9%) | - |
Policy/system capacity surveillancea | 2 (33.3%) | 32 (60.4%) | - |
Collecting data from grassroot level | 2 (33.3%) | 30 (56.6%) | - |
Conducting surveys | 1 (16.7%) | 14 (26.4%) | - |